Literature DB >> 6260561

Interaction of vasoactive intestinal peptide with human blood mononuclear cells.

J M Guerrero, J C Prieto, F L Elorza, R Ramirez, R Goberna.   

Abstract

The binding of vasoactive intestinal peptide (VIP) and the stimulation of adenylate cyclase were studied in mononuclear cells from human peripheral blood. The binding depended on time, temperature and pH, and was reversible, saturable and specific. Binding studies suggested the presence of 2 classes of binding site: a class with high affinity (Kd = 2.4 X 10(-10)M) and low capacity (8 fmoles/10(6) cells), and a class with low affinity (Kd = 8.0 X 10(-8)M) and high capacity (800 fmoles/10(6) cells) at 15 degrees C. Secretin displaced [125I]VIP from the cells with a 400-fold lower affinity than VIP, but glucagon, somatostatin and insulin did not show any effect. VIP was a potent and efficient stimulator of cyclic AMP production. The stimulation was observed at a concentration as low as 3 X 10(-11)M and depended on time, temperature and pH. Maximal cyclic AMP production (4-fold above basal levels) was observed with 10(-9) M at 15 degrees. Half-maximal response was obtained at 10(-10)M VIP. Secretin was an agonist of VIP but exhibited a 7000 times lower potency. Peripheral blood mononuclear cells constitute an easily accessible and suitable system for the study of VIP action in different physiological and pathophysiological conditions.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6260561     DOI: 10.1016/0303-7207(81)90052-6

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  12 in total

1.  Vasoactive intestinal peptide stimulates immunoglobulin production and growth of human B cells.

Authors:  C Ishioka; A Yoshida; H Kimata; H Mikawa
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

Review 2.  Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.

Authors:  Mario Delgado; Doina Ganea
Journal:  Amino Acids       Date:  2011-12-03       Impact factor: 3.520

3.  Selective effects of vasoactive intestinal peptide on the mitogenic response of murine T cells.

Authors:  C A Ottaway
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

4.  Priming effect of vasoactive intestinal peptide on the respiratory burst of neutrophils non-mediated by plasma membrane receptors.

Authors:  M A López-González; M Lucas
Journal:  Experientia       Date:  1994-05-15

5.  Human intraepithelial lymphocytes. Immunomodulation and receptor binding of vasoactive intestinal peptide.

Authors:  A I Roberts; A Panja; R E Brolin; E C Ebert
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

6.  Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes.

Authors:  K Dharmsathaphorn; V Harms; D J Yamashiro; R J Hughes; H J Binder; E M Wright
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

7.  Modification of lymphocyte traffic by vasoactive neurotransmitter substances.

Authors:  T C Moore
Journal:  Immunology       Date:  1984-07       Impact factor: 7.397

Review 8.  Clinical aspects of the melatonin action: impact of development, aging, and puberty, involvement of melatonin in psychiatric disease and importance of neuroimmunoendocrine interactions.

Authors:  F Waldhauser; B Ehrhart; E Förster
Journal:  Experientia       Date:  1993-08-15

9.  Depression of lymphocyte traffic in sheep by vasoactive intestinal peptide (VIP).

Authors:  T C Moore; C H Spruck; S I Said
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

10.  Suppression of CCL2/MCP-1 and CCL5/RANTES expression by nociceptin in human monocytes.

Authors:  David E Kaminsky; Thomas J Rogers
Journal:  J Neuroimmune Pharmacol       Date:  2007-09-15       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.